Generation Bio (GBIO) News Today $0.95 +0.00 (+0.18%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?January 17, 2025 | finance.yahoo.comGeneration Bio Insider Transactions Over The Last YearJanuary 16, 2025 | finance.yahoo.comGeneration Bio Co. (NASDAQ:GBIO) Director Acquires $82,450.00 in StockJanuary 15, 2025 | insidertrades.comAnthony G. Quinn Acquires 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) StockGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) Director Anthony G. Quinn acquired 85,000 shares of the business's stock in a transaction dated Monday, January 13th. The stock was acquired at an average cost of $0.97 per share, for a total transaction of $82,450.00. Following the transaction, the director now owns 299,286 shares of the company's stock, valued at $290,307.42. This represents a 39.67 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.January 14, 2025 | marketbeat.comAnthony G. Quinn Acquires 125,791 Shares of Generation Bio Co. (NASDAQ:GBIO) StockGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) Director Anthony G. Quinn acquired 125,791 shares of the business's stock in a transaction dated Friday, January 10th. The stock was purchased at an average price of $0.96 per share, with a total value of $120,759.36. Following the completion of the transaction, the director now directly owns 214,286 shares of the company's stock, valued at $205,714.56. This trade represents a 142.14 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.January 14, 2025 | marketbeat.comNeedham & Company LLC Has Lowered Expectations for Generation Bio (NASDAQ:GBIO) Stock PriceJanuary 11, 2025 | americanbankingnews.comStrategic Shift Towards T-cell Autoimmune Therapies Boosts Generation Bio’s ProspectsJanuary 9, 2025 | markets.businessinsider.comCautious Optimism for Generation Bio Amid Strategic Focus and Valuation ConcernsJanuary 9, 2025 | markets.businessinsider.comGeneration Bio (NASDAQ:GBIO) Price Target Lowered to $8.00 at Needham & Company LLCNeedham & Company LLC dropped their target price on Generation Bio from $10.00 to $8.00 and set a "buy" rating on the stock in a report on Wednesday.January 8, 2025 | marketbeat.comStrategic Shift and Focus on In Vivo siRNA Therapeutics: Generation Bio’s Streamlined Path ForwardJanuary 7, 2025 | markets.businessinsider.comTD Cowen Sticks to Their Hold Rating for Generation Bio (GBIO)January 7, 2025 | markets.businessinsider.comGeneration Bio Restructures Leadership and Focuses on siRNAJanuary 7, 2025 | markets.businessinsider.comGeneration Bio chief scientific officer Matthew Stanton to leave roleJanuary 7, 2025 | msn.comGeneration Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune DiseasesJanuary 6, 2025 | globenewswire.comShort Interest in Generation Bio Co. (NASDAQ:GBIO) Grows By 16.3%Generation Bio Co. (NASDAQ:GBIO - Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,780,000 shares, a growth of 16.3% from the November 30th total of 1,530,000 shares. Based on an average daily volume of 223,300 shares, the days-to-cover ratio is presently 8.0 days. Approximately 4.2% of the shares of the stock are sold short.December 30, 2024 | marketbeat.comGeneration Bio Co Ordinary SharesDecember 3, 2024 | morningstar.comBaker BROS. Advisors LP Buys 737,988 Shares of Generation Bio Co. (NASDAQ:GBIO)Baker BROS. Advisors LP grew its stake in Generation Bio Co. (NASDAQ:GBIO - Free Report) by 61.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,944,945 shares of the company's stock after buying an additionalDecember 2, 2024 | marketbeat.comGeneration Bio Co. Reports Q3 2024 Financials and ProgressNovember 22, 2024 | markets.businessinsider.comGeneration Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdlesNovember 15, 2024 | investing.comGeneration Bio (NASDAQ:GBIO) Stock, Option ChainNovember 11, 2024 | benzinga.comFY2024 EPS Estimates for Generation Bio Increased by WedbushGeneration Bio Co. (NASDAQ:GBIO - Free Report) - Stock analysts at Wedbush increased their FY2024 earnings per share estimates for Generation Bio in a research note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per sNovember 11, 2024 | marketbeat.comEarnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their ForecastsNovember 10, 2024 | finance.yahoo.comHold Rating Maintained for Generation Bio Amid Technological Progress and Timeline UncertaintyNovember 7, 2024 | markets.businessinsider.comOptimistic Buy Rating for Generation Bio Driven by mRNA Advances and Strong Financial PositionNovember 7, 2024 | markets.businessinsider.comPromising Pipeline and Strong Financials Affirm Buy Rating for Generation BioNovember 7, 2024 | markets.businessinsider.comGeneration Bio Reports Recent Business Highlights and Third Quarter 2024 Financial ResultsNovember 7, 2024 | markets.businessinsider.comGeneration Bio: Hold Rating Due to Positive Developments and Uncertain IND TimelinesNovember 7, 2024 | markets.businessinsider.comBullish Generation Bio Insiders Loaded Up On US$778.9k Of StockOctober 31, 2024 | uk.finance.yahoo.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in OctoberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 1,740,000 shares, a drop of 13.4% from the September 30th total of 2,010,000 shares. Based on an average trading volume of 101,500 shares, the short-interest ratio is currently 17.1 days. Approximately 3.6% of the shares of the stock are sold short.October 29, 2024 | marketbeat.comNeedham & Company LLC Reiterates "Buy" Rating for Generation Bio (NASDAQ:GBIO)Needham & Company LLC reiterated a "buy" rating and issued a $10.00 price objective on shares of Generation Bio in a research note on Wednesday.October 23, 2024 | marketbeat.comGeneration Bio presents preclinical data on ctLNP and iqDNAOctober 22, 2024 | markets.businessinsider.comGeneration Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual CongressOctober 22, 2024 | globenewswire.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in SeptemberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 2,010,000 shares, a drop of 6.1% from the September 15th total of 2,140,000 shares. Based on an average trading volume of 104,700 shares, the days-to-cover ratio is currently 19.2 days. Approximately 4.1% of the company's shares are sold short.October 16, 2024 | marketbeat.comGeneration Bio Co. (GBIO)October 2, 2024 | finance.yahoo.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in SeptemberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,140,000 shares, a growth of 13.8% from the August 31st total of 1,880,000 shares. Based on an average daily volume of 116,800 shares, the short-interest ratio is presently 18.3 days. Approximately 4.4% of the shares of the stock are sold short.September 29, 2024 | marketbeat.comGeneration Bio to Present at the 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comGeneration Bio (NASDAQ:GBIO) Stock Price Down 0.4%Generation Bio (NASDAQ:GBIO) Trading Down 0.4%September 6, 2024 | marketbeat.comRunway's Gen-3 Turbo AI video generator just got a big upgrade — here’s what’s newAugust 22, 2024 | msn.comQ3 2024 Earnings Forecast for Generation Bio Co. (NASDAQ:GBIO) Issued By WedbushGeneration Bio Co. (NASDAQ:GBIO - Free Report) - Equities research analysts at Wedbush reduced their Q3 2024 earnings estimates for shares of Generation Bio in a research report issued on Wednesday, August 7th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings ofAugust 12, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesAugust 10, 2024 | finance.yahoo.comBuy Rating Affirmed for Generation Bio on Strong Financials and Technological AdvancementsAugust 9, 2024 | markets.businessinsider.comGeneration Bio's (GBIO) "Outperform" Rating Reaffirmed at WedbushWedbush reiterated an "outperform" rating and issued a $5.00 target price on shares of Generation Bio in a research report on Thursday.August 8, 2024 | marketbeat.comThe bra trend Gen Z are ditching fast — and it’s not what you thinkAugust 7, 2024 | nypost.comGeneration Bio Reports Second Quarter 2024 Financial ResultsAugust 7, 2024 | finance.yahoo.comGeneration Bio to Present at the Canaccord Genuity 44th Annual Growth ConferenceAugust 6, 2024 | globenewswire.comCompanies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In GrowthAugust 3, 2024 | finance.yahoo.comPrice T Rowe Associates Inc. MD Boosts Stock Position in Generation Bio Co. (NASDAQ:GBIO)Price T Rowe Associates Inc. MD lifted its holdings in Generation Bio Co. (NASDAQ:GBIO - Free Report) by 28.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,878,361 shares of the company's stock after purchasing an addAugust 1, 2024 | marketbeat.comGen Z parents have amazing sex, new study reveals — millennials, not so muchJuly 31, 2024 | nypost.comGeneration Bio Co. (NASDAQ:GBIO) Shares Bought by Bellevue Group AGBellevue Group AG grew its position in Generation Bio Co. (NASDAQ:GBIO - Free Report) by 6.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,861,575 shares of the company's stock after purchasing an addiJuly 28, 2024 | marketbeat.comAcadian Asset Management LLC Raises Position in Generation Bio Co. (NASDAQ:GBIO)Acadian Asset Management LLC raised its stake in shares of Generation Bio Co. (NASDAQ:GBIO - Free Report) by 113.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 479,835 shares of the company'sJuly 25, 2024 | marketbeat.com Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address GBIO Media Mentions By Week GBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBIO News Sentiment▼1.130.48▲Average Medical News Sentiment GBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBIO Articles This Week▼71▲GBIO Articles Average Week Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HRTX News AMLX News NGNE News ATAI News DMAC News URGN News ELDN News LFCR News FHTX News BNTC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GBIO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GBIO Stock Alerts